ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer
Authors: Earl, H.M., Hiller, L., Dunn, J.A., Blenkinsop, C., Grybowicz, L., Vallier, A.-L., Abraham, J., Thomas, J., Provenzano, E., Hughes-Davies, L., McAdam, K., Chan, S., Ahmad, R., Hickish, T., Houston, S., Rea, D., Bartlett, J., Caldas, C., Cameron, D., Hayward, L.
Journal: CANCER RESEARCH
Publication Date: 01/05/2015
Volume: 75
eISSN: 1538-7445
ISSN: 0008-5472
DOI: 10.1158/1538-7445.SABCS14-PD2-3
Source: Web of Science